Menu Menu

ABUS    Arbutus Biopharma Corp    1447028    
Income Statement
Revenue 1,339,000
Net Income -19,717,000
Profit Margin -1472.52%

Balance Sheet
Current Assets 132,777,000
Assets 140,441,000
Current Liabilities 18,923,000
Liabilities 33,551,000
Equity 106,890,000
Shares Out 188,782,000

Cash Flow Statement
Operating Cash Flow -54,535,000
Investing Cash Flow 9,537,000

Market Analysis
Market Cap 783,445,318
Price 3.20
BVPS 0.57
PB 5.63
EPS -0.44
PS 146.27
FCF -44,998,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/29
Apr May Jun
5/02 -0.10
Jul Aug Sep
8/01 -0.11
Oct Nov Dec
11/07

Find a discrepancy? The most accurate way to find company fundamental data is to view ABUS documents filed with the SEC.


ABUS Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: